Human | HPE6 | 117190 | holoprosencephaly 6 | |
Human | NDUFAF2 | 91942 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | |
Human | C20orf7 | 79133 | | |
Human | MCCC1 | 56922 | methylcrotonoyl-CoA carboxylase 1 (alpha) | |
Human | C10orf2 | 56652 | chromosome 10 open reading frame 2 | |
Human | MRAP | 56246 | melanocortin 2 receptor accessory protein | |
Human | PNPO | 55163 | pyridoxamine 5'-phosphate oxidase | |
Human | NDUFAF4 | 29078 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 4 | |
Human | ACAD9 | 28976 | acyl-CoA dehydrogenase family, member 9 | |
Human | UQCRQ | 27089 | ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa | |
Human | MLYCD | 23417 | malonyl-CoA decarboxylase | |
Human | ADIPOQ | 9370 | adiponectin, C1Q and collagen domain containing | Adiponectin may against exercise-induced hypoglycemia by directly enhancing the oxidation of alternate fuel in type 1 diabetic children and adolescents |
Human | SUCLA2 | 8803 | succinate-CoA ligase, ADP-forming, beta subunit | |
Human | VEGFA | 7422 | vascular endothelial growth factor A | Effects of hyper- and hypoglycemia on blood VEGF levels may be of relevance for the understanding of VEGF alterations in different pathological states such as diabetes mellitus |
Human | UQCRB | 7381 | ubiquinol-cytochrome c reductase binding protein | |
Human | TNF | 7124 | tumor necrosis factor | In non-diabetic subjects, hypoglycaemia downregulated the production capacity of TNFalpha |
Human | TK2 | 7084 | thymidine kinase 2, mitochondrial | |
Human | ABCC8 | 6833 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Loss of consciousness due to hypoglycemia Mental retardation due to repeated episodes of hypoglycemia |
Human | SLC22A5 | 6584 | solute carrier family 22 (organic cation/carnitine transporter), member 5 | |
Human | SLC16A1 | 6566 | solute carrier family 16 (monocarboxylate transporter), member 1 | Loss on consciousness due to hypoglycemia These studies show that promoter-activating mutations in exercise-induced hyperinsulinism induce SLC16A1 expression in beta cells, permitting pyruvate uptake and pyruvate-stimulated insulin release despite ensuing hypoglycemia |
Human | SLC2A4 | 6517 | solute carrier family 2 (facilitated glucose transporter), member 4 | observed differential response of individual isoforms GLUT1, GLUT3, & GLUT4 in neutrophils and granulocytes to hypoglycemia may represent a mechanism to protect the cells from the stress of glucose deprivation |
Human | SLC2A3 | 6515 | solute carrier family 2 (facilitated glucose transporter), member 3 | observed differential response of individual isoforms GLUT1, GLUT3, & GLUT4 in neutrophils and granulocytes to hypoglycemia may represent a mechanism to protect the cells from the stress of glucose deprivation |
Human | SLC2A1 | 6513 | solute carrier family 2 (facilitated glucose transporter), member 1 | observed differential response of individual isoforms GLUT1, GLUT3, & GLUT4 in neutrophils and granulocytes to hypoglycemia may represent a mechanism to protect the cells from the stress of glucose deprivation |
Human | PCSK1 | 5122 | proprotein convertase subtilisin/kexin type 1 | |
Human | PCCB | 5096 | propionyl CoA carboxylase, beta polypeptide | |